Report cover image

COVID-19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Publisher GlobalData
Published Dec 16, 2022
Length 112 Pages
SKU # GBDT17643604

Description

COVID-19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Summary

GlobalData's Medical Devices sector report, “COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

COVID-19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) are used to amplify and detect the specific nucleic acid sequences of SARS-CoV-2 virus at the point-of-care.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

112 Pages
  • About GlobalData
    • COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) Overview
    • COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) - Pipeline Products by Stage of Development
    • COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) - Pipeline Products by Territory
    • COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) - Pipeline Products by Regulatory Path
    • COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) - Pipeline Products by Estimated Approval Date
    • COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) - Ongoing Clinical Trials
    • COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) Companies – Pipeline Products by Stage of Development
    • COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) –Companies Pipeline Products by Stage of Development
    • Aegea Biotechnologies Inc Company Overview
    • Aegis Sciences Corp Company Overview
    • Alveo Technologies Company Overview
    • Anavasi Diagnostics Company Overview
    • Anitoa Systems LLC Company Overview
    • Antigen Discovery Inc Company Overview
    • Aptorum Group Ltd Company Overview
    • Attoplex Co Ltd Company Overview
    • Baebies Inc Company Overview
    • Bhushan J. Toley Lab Company Overview
    • Biocartis Group NV Company Overview
    • BioLayer Corporation Limited Company Overview
    • BiologyWorks Inc Company Overview
    • Biyani Biosolutions Pvt Ltd Company Overview
    • CAMPTON Diagnostics UG Company Overview
    • CardiAI Inc Company Overview
    • Columbia University Company Overview
    • Columbia University Fertility Center Company Overview
    • Coyote Bioscience Co Ltd Company Overview
    • Credo Diagnostics Biomedical Pte Ltd Company Overview
    • Cue Health Inc Company Overview
    • Curiosity Diagnostics Sp zoo Company Overview
    • DiaCarta Inc Company Overview
    • DNA Xperts Pvt Ltd Company Overview
    • Eurofins Scientific SE Company Overview
    • FemtoDx Inc Company Overview
    • Flambeau Diagnostics Company Overview
    • Fluxergy LLC Company Overview
    • genedrive plc Company Overview
    • Hangzhou FasTech Biotechnology Co Ltd Company Overview
    • Harvard University Company Overview
    • ID Genomics Inc Company Overview
    • Jiangsu Qitian Gene Biotechnology Co Ltd Company Overview
    • KogeneBiotech Co Ltd Company Overview
    • Lamprogen Inc Company Overview
    • Lucira Health Inc Company Overview
    • Luminex Corp Company Overview
    • Lynntech Inc Company Overview
    • Mammoth Biosciences Inc Company Overview
    • McMaster University Company Overview
    • Meridian Bioscience Inc Company Overview
    • Merlin Biomedical (Xiamen) Co Ltd Company Overview
    • Mesa Biotech Inc Company Overview
    • Microgem International Plc Company Overview
    • Midge Medica GmbH Company Overview
    • NDFOS Co Ltd Company Overview
    • OxDX Ltd Company Overview
    • Patanjali Pharma Pvt Ltd Company Overview
    • PathogenDx, Inc. Company Overview
    • Pepex Biomedical, Inc. Company Overview
    • Prenetics Ltd Company Overview
    • Prime Discoveries Inc Company Overview
    • Princeton University Company Overview
    • Prominex Inc Company Overview
    • QuikPath Pte Ltd Company Overview
    • RNA Disease Diagnostics Inc Company Overview
    • Sense Biodetection Ltd Company Overview
    • Sentebiolab Biotechnology Company Overview
    • Shenzhen Second People's Hospital Company Overview
    • Shimadzu Corp Company Overview
    • Shionogi & Co Ltd Company Overview
    • Tangen Biosciences Inc Company Overview
    • Todos Medical Company Overview
    • Uh-OH Labs Inc Company Overview
    • University of California Berkeley Company Overview
    • University of Illinois at Urbana-Champaign Company Overview
    • University of Texas Southwestern Medical Center Company Overview
    • Veredus Laboratories Pte Ltd Company Overview
    • Visby Medical Inc Company Overview
    • XP Diagnostics GmbH Company Overview
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us